Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,546 | 4,108 | 4,569 | 4,048 | 4,255 |
| Receivables | 13,479 | 14,866 | 12,831 | 12,486 | 15,309 |
| Inventories | 22,816 | 23,245 | 25,990 | 25,130 | 24,136 |
| Other current assets | 3,061 | 2,898 | 3,401 | 4,766 | 4,448 |
| TOTAL | $44,902 | $45,117 | $46,791 | $46,430 | $48,148 |
| Non-Current Assets | |||||
| PPE Net | 5,009 | 5,106 | 5,221 | 4,758 | 4,492 |
| Intangibles | 19,090 | 67,456 | 69,780 | 70,068 | 71,377 |
| Other Non-Current Assets | 10,800 | 8,965 | 9,447 | 7,656 | 9,144 |
| TOTAL | $34,899 | $81,527 | $84,448 | $82,482 | $85,013 |
| Total Assets | $79,801 | $126,644 | $131,239 | $128,912 | $133,161 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 35,958 | 36,956 | 3,606 | 3,720 | 3,720 |
| Accounts payable and accrued liabilities | 4,808 | 4,787 | 5,283 | 5,711 | 6,044 |
| Other current liabilities | 14,837 | 13,215 | 13,862 | 13,190 | 14,716 |
| TOTAL | $55,603 | $54,958 | $22,751 | $22,621 | $25,677 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 34,252 | 31,960 | 31,890 |
| Other Non-Current Liabilities | 8,646 | 7,636 | 8,207 | 6,320 | 6,010 |
| TOTAL | $9,363 | $8,346 | $43,166 | $39,044 | $38,672 |
| Total Liabilities | $64,966 | $63,304 | $65,917 | $61,665 | $64,349 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,421 | 4,407 | 4,362 | 4,361 | 4,343 |
| Common Shares | 442 | 441 | 436 | 436 | 434 |
| Retained earnings | -208,350 | -158,010 | -158,028 | -153,226 | -150,299 |
| Other shareholders' equity | -14,361 | -15,670 | -13,059 | -14,868 | -14,774 |
| TOTAL | $14,835 | $63,340 | $65,322 | $67,247 | $68,812 |
| Total Liabilities And Equity | $79,801 | $126,644 | $131,239 | $128,912 | $133,161 |